recent news act venture capital portfolio

Munich Re acquire Allfinanz for €48m...

more>

Cappella Demonstrates Clinical Benefits in Treating Coronary Bifurcations...

more>

S3 Acquires Acacia...

more>

Novate Medical Ltd secures €4m funding from ACT Venture Capital, Seroba Bioventures and Enterprise Ireland....

more>

ACT Venture Capital is Ireland's leading venture capital firm. Founded as an independent operation in 1994, ACT has completed over 70 investments, principally in technology based companies serving global markets.

ACT takes a stage diversified approach to investing in exceptional companies operating in Information & Communications Technology, Internet & Media, Healthcare and the Development Capital sector.

By leveraging the collective experience of our investment professionals as well as our extensive network of contacts, ACT takes a value added approach to technology investing. We take an active role in our portfolio companies, through board participation and beyond, to support talented entrepreneurs to achieve success on a world stage.

ACT has raised over €350 million sourced from leading American, European, Irish and UK institutions. We provide capital to high potential companies located within Ireland, the UK and Europe in the range of €1 million to €15 million.